135 related articles for article (PubMed ID: 3795623)
1. Assessment of the cardiohemodynamic effects of ibopamine, an orally-active dopamine analogue, in the anesthetized open-chest guinea pig and the isolated guinea pig atria.
Matsui K; Imai S
Jpn J Pharmacol; 1986 Oct; 42(2):217-27. PubMed ID: 3795623
[TBL] [Abstract][Full Text] [Related]
2. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
Kopia GA; Ohlstein EH; Ruffolo RR
J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the positive inotropic effect of ibopamine in the blood-perfused canine papillary muscle.
Kawahara K; Inui J
J Cardiovasc Pharmacol; 1985; 7(2):316-20. PubMed ID: 2581086
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
Shebuski RJ; Fujita T; Smith JM; Ruffolo RR
J Pharmacol Exp Ther; 1987 Apr; 241(1):6-12. PubMed ID: 3033210
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
Nichols AJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
[TBL] [Abstract][Full Text] [Related]
7. Effect of dopamine, ibopamine, and epinine on alpha- and beta-adrenoceptors in canine pulmonary circulation.
Shebuski RJ; Smith JM; Ruffolo R
Fundam Clin Pharmacol; 1989; 3(3):211-21. PubMed ID: 2548941
[TBL] [Abstract][Full Text] [Related]
8. Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation.
Bernardi L; Perlini S; Soffiantino F; Farilla C; Calciati A; Soldá PL; Paro M; Merlo L; Marchetti G; Finardi G
Eur J Pharmacol; 1989 May; 164(3):415-24. PubMed ID: 2767116
[TBL] [Abstract][Full Text] [Related]
9. Coronary vascular activity of the novel inotropic pro-drug ibopamine and the de-esterified active form epinine.
Ohlstein EH; Kopia GA; Ruffolo RR
Arzneimittelforschung; 1988 Dec; 38(12):1790-2. PubMed ID: 3245851
[TBL] [Abstract][Full Text] [Related]
10. Activity of ibopamine on some isolated organs.
Ferrini R; Miragoli G
Arzneimittelforschung; 1986 Feb; 36(2A):312-7. PubMed ID: 3458467
[TBL] [Abstract][Full Text] [Related]
11. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
Merlo L; Ghirardi P; Brusoni B; Mussini E; Marchetti G
Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of the positive inotropic action evoked by epinine on the rabbit isolated papillary muscle at different rates of beating.
Brodde OE; Motomura S; Schümann HJ
Clin Exp Pharmacol Physiol; 1979; 6(1):41-51. PubMed ID: 216511
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of ibopamine.
Itoh H
Am J Med; 1991 May; 90(5B):36S-42S. PubMed ID: 1675550
[TBL] [Abstract][Full Text] [Related]
14. The dopamine congener, ibopamine, in congestive heart failure.
Ren JH; Unverferth DV; Leier CV
J Cardiovasc Pharmacol; 1984; 6(5):748-55. PubMed ID: 6209476
[TBL] [Abstract][Full Text] [Related]
15. Early cardiovascular changes with ibopamine: evidence for a biphasic haemodynamic action.
Hogg KJ; Hornung RS; Howie CA; Hillis WS
Br J Clin Pharmacol; 1987 Oct; 24(4):435-42. PubMed ID: 3689625
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamine.
Nichols AJ; Shebuski RJ; Ruffolo RR
Eur J Pharmacol; 1987 Sep; 141(3):515-8. PubMed ID: 3666046
[TBL] [Abstract][Full Text] [Related]
17. Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
Henwood JM; Todd PA
Drugs; 1988 Jul; 36(1):11-31. PubMed ID: 3063492
[TBL] [Abstract][Full Text] [Related]
18. Ibopamine--how should it be used?
Bussmann WD; Wienhöfer K; Frik R
Cardiology; 1988; 75 Suppl 1():126-37. PubMed ID: 3069210
[TBL] [Abstract][Full Text] [Related]
19. Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs.
Marchetti G; Merlo L
Arzneimittelforschung; 1986 Feb; 36(2A):331-3. PubMed ID: 3707644
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
